T2-weighted MRI screening algorithm for patients with asymmetric sensorineural hearing loss

We read with interest the article by Valesano et al. [1]. As noted in the article, gadolinium-enhanced T1-weighted MRI (GdT1WI) has been the “gold standard” imaging study for many years in the diagnosis of vestibular schwannoma in asymmetric sensorineural hearing loss (ASNHL). In recent years, with improved imaging technology, a push toward non-contrast T2-weighted MRI (T2WI) for screening of patients with ASNHL has been made in an effort to decrease patient exposure to gadolinium, acquisition time, and cost.